5-question survey may increase COPD diagnoses
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD). Researchers from David Geffen School of Medicine at UCLA, Olmsted Medical Center, Boehringer-Ingelheim Pharmaceuticals Inc , and Pfizer Inc, randomized 9,704 patients with no prior COPD diagnosis from US primary care practices in seven states into three groups based on treatment: Arm 1: COPD-PS plus spirometry; Arm 2: COPD-PS alone; Arm 3: usual care. Results showed that the rate of new COPD diagnoses within 8 weeks of visit 1 was ...